Clinical trial
Transfusion Effects in Myelodysplastic Patients: Limiting Exposure
NCT00202371 · Sanquin Research & Blood Bank Divisions, Other · Withdrawn
Key facts
| NCT number | NCT00202371 |
|---|---|
| Title | Transfusion Effects in Myelodysplastic Patients: Limiting Exposure |
| Official title | Transfusion Effects in Myelodysplastic Patients: Limiting Exposure (Temple) |
| Lead sponsor | Sanquin Research & Blood Bank Divisions, Other |
| Collaborators | Ministry of Health, Welfare and Sports, The Netherlands |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes |
| Intervention type | Procedure |
| Interventions | Red Blood Cell transfusion |
| Enrollment | 0 |
| Start date | Jul 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 24, 2023 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: